Target Price | JPY1,681.82 |
Price | JPY1,650.50 |
Potential |
1.90%
register free of charge
|
Number of Estimates | 11 |
11 Analysts have issued a price target Ono Pharmaceutical 2026 .
The average Ono Pharmaceutical target price is JPY1,681.82.
This is
1.90%
register free of charge
JPY2,500.00
51.47%
register free of charge
JPY1,400.00
15.18%
register free of charge
|
|
A rating was issued by 12 analysts: 1 Analysts recommend Ono Pharmaceutical to buy, 6 to hold and 5 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Ono Pharmaceutical stock has an average upside potential 2026 of
1.90%
register free of charge
|
Mar '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion JPY | 502.67 | 494.04 |
12.41% | 1.72% | |
EBITDA Margin | 36.15% | 22.67% |
4.77% | 37.28% | |
Net Margin | 24.91% | 12.65% |
2.74% | 49.22% |
11 Analysts have issued a sales forecast Ono Pharmaceutical 2025 . The average Ono Pharmaceutical sales estimate is
This results in the following potential growth metrics:
9 Analysts have issued an Ono Pharmaceutical EBITDA forecast 2025. The average Ono Pharmaceutical EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
5 Ono Pharmaceutical Analysts have issued a net profit forecast 2025. The average Ono Pharmaceutical net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Mar '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share JPY | 266.61 | 133.00 |
15.49% | 50.11% | |
P/E | 12.41 | |
EV/Sales | 1.54 |
5 Analysts have issued a Ono Pharmaceutical forecast for earnings per share. The average Ono Pharmaceutical EPS is
This results in the following potential growth metrics and future valuations:
Ono Pharmaceutical...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.